Single-Use Bioprocessing Market: Current Analysis and Forecast (2021-2027)
$3500 – $6860
Emphasis on Product Type (Media Bags and Containers, Filtration Assemblies, Single-Use Bioreactors, Disposable Mixers, Others), Application (Filtration Storage, Cell Culture, Mixing, Purification); End-User (Life Science R&D, Biopharmaceutical Manufacturers); and Region & Country.
Single-use systems are biopharmaceutical production (bioprocessing) products that are only used once and then discarded. Single-use systems are often made up of plastic components that have been disinfected and sealed using gamma irradiation. The prevalence of chronic diseases has been continuously increasing worldwide. They are the world’s leading killers, accounting for more than 63% of all deaths. If nothing is done to reverse this trend, the number of people dying from chronic diseases will increase by 17% in the following ten years. This has led to expanding clinical research activities to decipher the potential of biotherapeutics against various disease areas is expected to have a positive influence on the market for single-use bioprocessing.
Single-use bioprocessing in biopharmaceutical firms is expected to see healthy expansion in the future because of its numerous advantages over traditional bioprocessing technologies. These technologies have several advantages, including lower initial investment and R&D costs, lower labor and material costs, and the ability to be readily disposed of. Furthermore, as compared to stainless steel reactors used in conventional bioprocessing, these single-use bioprocessing units have a 35% better CO2 balance, which is why they are widely used by the manufacturer. Merck KGaA announced an extra EUR 40 million investment in Asia in 2018 for two years to establish a solid manufacturing and distribution network.
Furthermore, the increasing approval of drugs and other biologics has increased the demand for single-use disposables such as media bags and containers. The Center for Drug Evaluation and Research (CDER) approved 53 new medications in 2020. (CDER). Each year, the number of new medicinal items approved by the FDA fluctuates greatly: in 2016, just over 20 new pharmaceuticals were approved, while in 2018, almost 60 new products were approved. In the year 2020, 53 new medicines were approved. In 2019, many new pharmaceuticals will be developed, notably in the pharmaceutical business in the United States. Under the United States alone, nearly 1,100 novel drugs were in development for cancer and cancer-related illnesses as of April 2019. Hundreds of innovative treatments for uncommon ailments, neurological disorders, and skin diseases were also in the works.
National Health Spending, % GDP
Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Corning Incorporated, Pall Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Rentschler Biopharma SE, Lonza, and Meissner Filtration Products, Inc are some of the prominent players operating in the global Single-Use Bioprocessing market. Several M&A’s along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.
Insights Presented in the Report
Based on the product type, the market is fragmented into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. The media bags and containers segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the growing adoption of media bags and containers in transportation and storage.
Amongst Applications, Filtration segment holds the major share”
Based on the application, the market is fragmented into filtration storage, cell culture, mixing, and purification. The filtration segment dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.
Based on end-user, the market is fragmented into life science R&D and biopharmaceutical manufacturers. In 2020, biopharmaceutical manufacturers accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period.
“North America signifies one of the largest markets of Single-Use Bioprocessing Market”
For a better understanding of the market dynamics of the Single-Use Bioprocessing market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the increased prevalence of chronic diseases and outbreak of COVID-19. The North American government has been investing heavily in the development of COVID-19 vaccines, treatments, and diagnostic tests, which is expected to increase demand for single-use bioreactors and, as a result, overall market growth.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
The Single-Use Bioprocessing Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
|1.2||Objective of the Study|
|1.5||Currency Used in Report|
|1.6||Scope of the Global Single-Use Bioprocessing Market Study|
|2.1||Research Methodology for the Global Single-Use Bioprocessing Market|
|2.1.1||Main Objective of the Global Single-Use Bioprocessing Market|
|7||GLOBAL SINGLE-USE BIOPROCESSING MARKET REVENUE|
|8.1||Media bags and containers|
|8.2||Quick launches of new product|
|9.1||Life Science R&D|
|11.1||NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET|
|11.1.3||Rest of North America|
|11.2||EUROPE SINGLE-USE BIOPROCESSING MARKET|
|11.2.6||Rest of Europe|
|11.3||ASIA PACIFIC SINGLE-USE BIOPROCESSING MARKET|
|11.3.6||Rest of Asia Pacific|
|11.4||REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET|
|13||LEGAL & REGULATORY FRAMEWORK|
|14.1||Demand Side Analysis|
|14.2||Supply Side Analysis|
|14.2.1||Top Product Launches|
|14.2.2||Top Business Partnerships|
|14.2.3||Top Merger & Acquisitions|
|15||VALUE CHAIN ANALYSIS|
|16||SINGLE-USE BIOPROCESSING MARKET OPPORTUNITIES|
|17||RSINGLE-USE BIOPROCESSING MARKET TRENDS & INSIGHTS|
|18.1||Porter’s Five forces analysis|
|18.1.1||Bargaining power of Supplier|
|18.1.2||Bargaining power of Buyer|
|18.1.4||Availability of Substitute|
|18.1.5||Threat of new Entrants|
|19.1||Thermo Fisher Scientific, Inc.|
|19.1.3||Key Product/Services Offerings|
|126.96.36.199||Financial Overview of Thermo Fisher Scientific, Inc.|
|188.8.131.52||Business Expansion and Investments|
|184.108.40.206||Merger and Acquisition|
|19.6||General Electric Company (GE Healthcare)|
|19.8||Rentschler Biopharma SE|
|19.1||Meissner Filtration Products, Inc|
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Single-Use Bioprocessing Market were the three major steps undertaken to create and analyze the adoption of Single-Use Bioprocessing for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Single-Use Bioprocessing sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detailed secondary study was conducted to obtain the historical market size of the Single-Use Bioprocessing through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Single-Use Bioprocessing market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are therapy, application, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of Single-Use Bioprocessing in every region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Single-Use Bioprocessing. Further, we conducted factor analysis using dependent and independent variables such as increasing cancer incidence and growing geriatric population. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the Single-Use Bioprocessing industry across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Single-Use Bioprocessing market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/ bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (USD) and the adoption rate of Single-Use Bioprocessing across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the Single-Use Bioprocessing market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Single-Use Bioprocessing market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, application, and end-user of the Single-Use Bioprocessing market.
Main Objective of the Single-Use Bioprocessing Market Study
The current & future market trends of Single-Use Bioprocessing were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of Single-Use Bioprocessing in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of product, application and end-user
- Define and analysis of the regulatory framework for the Single-Use Bioprocessing industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Single-Use Bioprocessing market for the major region
- Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India and Australia), and Rest of the World
- Company profiles of the Single-Use Bioprocessing market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry